Working Hours
Mon - Sat 9:00 - 6:00Brand Name: LORTINIL TZ
Composition: Ceftazidime & Tazobactam Injection
Manufacturer/Marketer: Aurobindo Pharma Ltd Veritaz Division
Dosage Form: Dry Powder for Injection
Packaging Type: Vial
Route of Administration: Intravenous (IV) / Intramuscular (IM)
Prescription Required: Yes
LORTINIL TZ Injection is a broad-spectrum antibiotic combination containing Ceftazidime and Tazobactam. Ceftazidime is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, while Tazobactam is a beta-lactamase inhibitor that enhances the effectiveness of Ceftazidime against resistant bacterial strains.
It is widely used in hospitals and clinical settings for the treatment of moderate to severe bacterial infections.
Indications:Respiratory tract infections
Urinary tract infections
Intra-abdominal infections
Skin and soft tissue infections
Bone and joint infections
Septicemia
Key Features:Broad-spectrum antibacterial coverage
Effective against beta-lactamase producing organisms
Suitable for critical care and hospital use
Manufactured by a reputed pharmaceutical company
Storage:Store in a cool, dry place below 25C. Protect from light and moisture.
Note: To be administered under the supervision of a qualified healthcare professional only.



Price:
Price 95.0 INR / Piece
Minimum Order Quantity : 50 Pieces
Quantity : 50 Pieces
Ingredients : Brand Name: LINTAZ 4.5 G Generic Name / Content: Piperacillin + Tazobactam Injection I.P. 4.5 g Company: Aurobindo Pharma Ltd LINTAZ 4.5 G Injection is a broadspectrum injectable antibiotic combining Piperacillin (a penicillinclass antibiotic) and Tazobactam (a betalactamase inhibitor). This dualaction formulation provides enhanced efficacy against betalactamase producing bacteria, covering a wide range of Grampositive and Gramnegative infections. Piperacillin disrupts bacterial cell wall synthesis, while Tazobactam prevents enzymatic degradation, ensuring stronger antibacterial activity. The sterile injectable form is intended for intravenous (IV) or intramuscular (IM) administration in hospitals and clinical settings. Indications Severe respiratory tract infections (pneumonia, bronchitis) Urinary tract infections (UTIs) Skin and soft tissue infections Intraabdominal infections Septicemia and bacteremia Gynecological infections Surgical prophylaxis Key Features Broadspectrum penicillin with betalactamase inhibitor Effective against resistant bacterial strains Rapid and reliable antibacterial action Sterile injectable formulation suitable for hospital use Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial) Category: Injectable / Parenteral Antibiotic Strength: 4.5 g per vial Content: Piperacillin + Tazobactam Packaging & Storage Supplied in sterile vial packaging Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision
Physical Form : Liquid
Drug Type : Injection
Price 319 INR / Vial
Minimum Order Quantity : 100 Vials
Quantity : 1 Pieces
Physical Form : Liquid
Drug Type : Injection
Price 306.5 INR / Piece
Minimum Order Quantity : 50 Pieces
Quantity : 50 Unit
Ingredients : ROPIN 0.20% 50ML Ropivacaine Hydrochloride Injection I.P. Brand: ROPIN Injection Content: Ropivacaine Hydrochloride I.P. 0.2% w/v (2 mg / ml) Company / Manufacturer: Neon Laboratories Ltd Pack: 50 ml Vial Category: Local Anesthetic / AmideType Regional AnestheticProduct Description ROPIN 0.20% 50ml Vial contains Ropivacaine Hydrochloride, a longacting amidetype local anesthetic solution formulated for parenteral administration. The 0.2% concentration is specifically designed to provide effective sensory nerve blockade while minimizing motor block, making it ideal for continuous pain relief. It is widely used in postoperative wards, intensive care units, and delivery rooms to provide stable, longlasting regional pain control during surgical recovery or childbirth with enhanced systemic safety margins.Key Uses Production of continuous epidural infusion analgesia for labor pain management during childbirth Postoperative pain management following major orthopedic, abdominal, or thoracic surgeries Continuous peripheral nerve blocks and infiltration anesthesia for local pain control Longterm acute pain management in intensive care settings How It Works Ropivacaine works by blocking the generation and conduction of nerve impulses. It diffuses into the nerve sheath and binds selectively to the intracellular sodium channels of nerve fibers. This action prevents the influx of sodium ions through the cell membrane, stopping the electrical depolarization of the nerve cell. By blocking these pathways, the drug temporarily prevents pain signals from traveling from the affected site up the spinal cord to the brain.Directions for Use Administer via epidural infusion, peripheral nerve block, or local tissue infiltration routes Visually check the solution inside the vial for any particles, leaks, or cloudiness before extraction Extract using clean, sterile syringes directly through the rubber stopper core Must be calculated, handled, and administered exclusively by a registered anesthesiologist or clinician Key Features Optimized concentration that provides reliable pain relief with minimal loss of skeletal muscle control Extended therapeutic window that delivers prolonged postsurgical and labor analgesia High volume 50 ml vial format designed to support continuous infusion pumps or repeated dosing protocols Fabricated under international sterile manufacturing standards by Neon Laboratories Ltd Possible Side Effects Hypotension or sudden temporary drop in systemic blood pressure Nausea, vomiting, or mild dizziness Important Safety Notes Storage Temperature: Store below 30 C in a cool, dry place. Protect from direct light lines and do not freeze. For local and regional blocks only; strictly contraindicated for intravenous regional anesthesia methods Avoid application directly into highly inflamed or infected tissue surfaces Schedule H Prescription Drug: Restricted for institutional supply to verified buyers with drug wholesale licenses
Physical Form : Liquid
Drug Type : Injection
Price 354.0 INR / Box
Minimum Order Quantity : 50 Boxes
Quantity : 50 Boxes
Ingredients : Brand Name: LIN+IV 600 mg Tablet Generic Name / Content: Linezolid Tablet I.P. 600 mg Company: Aurobindo Pharma Ltd LIN+IV 600 mg Tablet contains Linezolid, a synthetic oxazolidinoneclass antibiotic used for the treatment of serious Grampositive bacterial infections. It works by inhibiting bacterial protein synthesis, effectively stopping the growth and multiplication of susceptible bacteria. This oral formulation is suitable for patients requiring outpatient therapy or for hospital use when intravenous therapy is not needed. Indications Complicated skin and soft tissue infections Communityacquired pneumonia (CAP) Hospitalacquired pneumonia (HAP) Infections caused by methicillinresistant Staphylococcus aureus (MRSA) Vancomycinresistant Enterococcus faecium (VRE) infections Key Features Oxazolidinoneclass broadspectrum antibiotic Effective against multidrugresistant Grampositive bacteria Oral tablet formulation for easy administration Rapid onset of action Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Tablet Category: Oral Antibiotic (Oxazolidinone Class) Strength: 600 mg Content: Linezolid I.P. Packaging & Storage Supplied in blister packs or bottles as per packaging Store in a cool, dry place below 25 C Protect from light and moisture Use under qualified medical supervision
